Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

bioAffinity Technologies (BIAF) EPS (Basic): 2022-2025

Historic EPS (Basic) for bioAffinity Technologies (BIAF) over the last 4 years, with Sep 2025 value amounting to -$4.74.

  • bioAffinity Technologies' EPS (Basic) rose 2.07% to -$4.74 in Q3 2025 from the same period last year, while for Sep 2025 it was $10.40, marking a year-over-year increase of 289.44%. This contributed to the annual value of -$0.75 for FY2024, which is 17.58% up from last year.
  • As of Q3 2025, bioAffinity Technologies' EPS (Basic) stood at -$4.74, which was down 2,688.24% from -$0.17 recorded in Q2 2025.
  • In the past 5 years, bioAffinity Technologies' EPS (Basic) registered a high of $15.47 during Q4 2024, and its lowest value of -$4.84 during Q3 2024.
  • In the last 3 years, bioAffinity Technologies' EPS (Basic) had a median value of -$0.20 in 2024 and averaged $0.39.
  • Within the past 5 years, the most significant YoY rise in bioAffinity Technologies' EPS (Basic) was 6,050.00% (2024), while the steepest drop was 1,761.54% (2024).
  • Quarterly analysis of 4 years shows bioAffinity Technologies' EPS (Basic) stood at $0.22 in 2022, then plummeted by 218.18% to -$0.26 in 2023, then surged by 6,050.00% to $15.47 in 2024, then grew by 2.07% to -$4.74 in 2025.
  • Its EPS (Basic) stands at -$4.74 for Q3 2025, versus -$0.17 for Q2 2025 and -$0.16 for Q1 2025.